Gait characteristics track biological disease stages in Parkinson’s disease
This study demonstrates that quantitative gait characteristics derived from instrumented walkways and body-worn monitors can significantly differentiate between Stage 3 and Stage 4 of the NSD-ISS framework in Parkinson's disease, supporting their potential as objective digital markers for tracking biological disease progression.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Parkinson's disease is a condition that slowly changes how people move, often starting with a tremor or a stiffness in the limbs. While doctors have long used clinical scales to track how far the disease has progressed, these methods rely on what a patient can do at a specific moment, which can vary depending on the time of day or medication. Scientists are now looking for a way to map the disease based on its underlying biology rather than just its visible symptoms. A new framework called the Neuronal Alpha-Synuclein Disease-Integrated Staging System attempts to do this by dividing the disease into seven distinct stages, ranging from the earliest biological changes before symptoms appear to advanced disability. The goal is to create a precise roadmap of the illness, but for this map to be useful, researchers need reliable tools to measure where a person stands on it.
A team of researchers at the Translational and Clinical Research Institute in Newcastle, UK, set out to see if the way a person walks could serve as one of these reliable tools. They focused on the middle part of the disease spectrum, where symptoms are clearly present but not yet at the most severe levels. To test this, they recruited 119 people with Parkinson's disease who were part of a larger long-term study called ICICLE-GAIT. The researchers asked these participants to walk around a track while wearing two different types of equipment. One was a long, instrumented mat on the floor that recorded every step with high precision, and the other was a small sensor worn on the lower back that tracked movement continuously, even when the person turned corners.
The team first sorted the participants into two groups based on their current level of disability, using a standard rating scale that measures daily living activities. One group had milder difficulties, while the other had more significant challenges. They then compared the walking data from the two groups to see if the sensors could detect a difference. The results were clear: the sensors picked up distinct changes in how the two groups moved. People in the more advanced group walked with shorter steps and at a slower speed. Their steps were also less consistent, meaning the time between each step and the length of each stride varied more than in the group with milder symptoms. These differences were found in the speed of walking, the rhythm of the steps, and the steadiness of the movement.
The study found that these subtle changes in walking patterns were strong enough to distinguish between the two stages of the disease, even after accounting for factors like age and body weight. The instrumented mat on the floor was particularly good at detecting differences in how wide a person placed their feet, a measure of balance, while the sensor on the back was better at capturing the overall rhythm of the walk. This suggests that both methods offer valuable, objective data that could help doctors understand the progression of the disease more accurately than clinical observation alone.
However, the researchers are careful to note that this is an early step. The study only looked at two specific stages of the disease and relied on data collected in a controlled laboratory setting, not in the real world. The participants were also relatively new to the diagnosis, so the team could not yet see if these walking markers could track the disease through its most severe stages. Despite these limits, the work provides a proof of concept. It demonstrates that the way a person walks contains a digital signature of their disease stage, offering a potential new way to measure the invisible biological changes that drive Parkinson's disease. Future research will need to confirm if these findings hold true over many years and in everyday life, but the initial results suggest that the simple act of walking holds a key to understanding the complex journey of this condition.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.